MT Cancer Inst Fndtn; MT Can Spec — Missoula, Montana

MT Cancer Inst Fndtn; MT Can Spec is a clinical research site located in Missoula, Montana, United States 59802.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

MT Cancer Inst Fndtn; MT Can Spec has participated in 2 clinical trials.

Therapeutic areas: Non-Hodgkin's Lymphoma, Lymphoma, B-Cell.

Sponsors: Hoffmann-La Roche, Genentech, Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MT Cancer Inst Fndtn; MT Can Spec?

MT Cancer Inst Fndtn; MT Can Spec has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MT Cancer Inst Fndtn; MT Can Spec conducted?

MT Cancer Inst Fndtn; MT Can Spec has 2 clinical trials on record. Their work covers Non-Hodgkin's Lymphoma, Lymphoma, B-Cell.

Is MT Cancer Inst Fndtn; MT Can Spec accredited by Crixeo Health?

MT Cancer Inst Fndtn; MT Can Spec has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MT Cancer Inst Fndtn; MT Can Spec?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.